Transplant coronary artery disease - A novel model independent of cellular alloimmune response

被引:17
作者
Cantin, B
Wen, PZ
Zhu, DN
Dai, M
Panchal, SN
Billingham, ME
Gwathmey, JK
Valantine, HA
机构
[1] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA USA
[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA
[3] Gwathmey Inc, Cambridge, MA USA
关键词
transplantation; immunology; interleukins; coronary disease; immunohistochemistry;
D O I
10.1161/hc4601.099398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Allograft coronary atherosclerosis (TxCAD) is the leading cause of death after the first year after transplantation. TxCAD is believed to be a form of chronic rejection of the cardiac allografts. This study was undertaken to determine whether TxCAD could develop in the absence of a cellular alloimmune response. Methods and Results-Inbred lean Zucker rats (> 26 generations) served as donors and recipients of the cardiac grafts. Donor hearts were explanted at 60 or 90 days. Explanted hearts were processed for coronary artery histological analysis. Cytokine expression was determined by reverse transcription-polymerase chain reaction, and the presence of T cells within the explanted hearts was evaluated by immunohistochemistry. Forty-six transplantations were made, and TxCAD developed in all but one of the transplanted hearts. Overall, one third of the vessels examined were affected by TxCAD, and in roughly half of these vessels, the disease was severe. Native hearts were free of atherosclerosis. Interleukin-2 was absent from the transplanted hearts, and T cells were present in minimal amounts (<1 per low-power field). Conclusions-TxCAD developed in the absence of a cellular alloimmune response in these genetically similar donors and recipients. The observed TxCAD was significant and comparable to what is found in rat allografting models.
引用
收藏
页码:2615 / 2619
页数:5
相关论文
共 34 条
[1]  
Abbas AK, 2000, CELLULAR MOL IMMUNOL, P182
[2]   EXPERIMENTAL GRAFT ARTERIOSCLEROSIS .1. THE LEWIS-TO-F-344 ALLOGRAFT MODEL [J].
ADAMS, DH ;
TILNEY, NL ;
COLLINS, JJ ;
KARNOVSKY, MJ .
TRANSPLANTATION, 1992, 53 (05) :1115-1119
[3]  
BILLINGHAM ME, 1981, HEART TRANSPLANT, V2, P25
[4]  
Costanzo MR, 1998, J HEART LUNG TRANSPL, V17, P744
[5]  
COSTANZONORDIN MR, 1992, J HEART LUNG TRANSPL, V11, pS90
[6]   CARDIAC TRANSPLANTATION IN THE RAT .1. THE EFFECT OF HISTOCOMPATIBILITY DIFFERENCES ON GRAFT ARTERIOSCLEROSIS [J].
CRAMER, DV ;
QIAN, SQ ;
HARNAHA, J ;
CHAPMAN, FA ;
ESTES, LW ;
STARZL, TE ;
MAKOWKA, L .
TRANSPLANTATION, 1989, 47 (03) :414-419
[7]   CARDIAC TRANSPLANTATION IN THE RAT .2. ALTERATION OF THE SEVERITY OF DONOR GRAFT ARTERIOSCLEROSIS BY MODULATION OF THE HOST IMMUNE-RESPONSE [J].
CRAMER, DV ;
CHAPMAN, FA ;
WU, GD ;
HARNAHA, JB ;
QIAN, SQ ;
MAKOWKA, L .
TRANSPLANTATION, 1990, 50 (04) :554-558
[8]   Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection [J].
Derhaag, JG ;
Duijvestijn, AM ;
Damoiseaux, JGMC ;
Vriesman, PJCV .
TRANSPLANTATION, 2000, 69 (09) :1899-1906
[9]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[10]   The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation [J].
Fredrich, R ;
Toyoda, M ;
Czer, LSC ;
Galfayan, K ;
Galera, O ;
Trento, A ;
Freimark, D ;
Young, S ;
Jordan, SC .
TRANSPLANTATION, 1999, 67 (03) :385-391